A Phase 4 interventional study of Intrathecal bupivacaine, morphine and atropine and General anaesthesia in Postoperative Nausea and Vomiting, Postoperative Pain and Anesthesia, sponsored by Universitas Indonesia. Completed at 1 site in Indonesia. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2026-10-01.
Sponsored by Universitas Indonesia · Phase 4, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Laparoscopic abdominal surgery carries one of the highest risks of postoperative nausea and vomiting (PONV), and postoperative opioids given for pain are themselves emetogenic. Intrathecal morphine provides prolonged analgesia but increases nausea; intrathecal atropine 100 µg has been reported to reduce morphine-related nausea under spinal anaesthesia alone, but has not been tested within a combined spinal-general technique.
This randomised, open-label, parallel-group trial compared combined spinal-general anaesthesia (CSGA), hyperbaric bupivacaine 10 mg, morphine 100 µg and atropine 100 µg given intrathecally before induction, followed by general anaesthesia, with general anaesthesia (GA) alone in adults undergoing elective abdominal laparoscopy. Both groups received identical general anaesthesia, multimodal analgesia (paracetamol and ketorolac at skin closure), end-of-case ondansetron and neostigmine-atropine reversal.
The primary outcome was the occurrence of PONV within 24 hours after surgery. Secondary outcomes were postoperative pain, rescue antiemetic and rescue opioid requirements, intraoperative fentanyl consumption and perioperative haemodynamics.
summarise Methods: setting, randomisation by computer-generated sequence, spinal technique at L4-5 with 27-G Quincke needle, target T6 block, induction and maintenance regimen, assessment schedule at 1, 2, 6, 12 and 24 h, sample size assumptions of 75% vs 40% PONV at α 0.05 and 80% power, per-protocol analysis.
638 studies on the registry are indexed under Postoperative Nausea and Vomiting; 110 are open to participants now.
This study's enrollment of 63 is below the median of 112 across 529 interventional studies indexed under Postoperative Nausea and Vomiting.
Browse Postoperative Nausea and Vomiting studies →Universitas Indonesia is the lead sponsor of 39 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before induction, spinal anaesthesia at L4-5 in the sitting position with a 27-G Quincke needle: 0.5% hyperbaric bupivacaine 10 mg, preservative-free morphine 100 µg and atropine sulphate 100 µg, made up to 4 mL with 0.9% saline, targeting a T6 sensory level. General anaesthesia was then induced and maintained as in the comparator arm.
Drug: Intrathecal bupivacaine, morphine and atropine · Procedure: General anaesthesia · Drug: Multimodal analgesia and antiemetic prophylaxis
General anaesthesia without any neuraxial block: induction with lidocaine 1.5 mg/kg, fentanyl 2 µg/kg, propofol 2 mg/kg and rocuronium 0.6 mg/kg; maintenance with sevoflurane in oxygen-air at target MAC 0.8, with fentanyl 25-50 µg boluses for haemodynamic response.
Procedure: General anaesthesia · Drug: Multimodal analgesia and antiemetic prophylaxis
Drug pages: BupivacaineStudies of BupivacaineBupivacaine pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · MorphineStudies of MorphineMorphine pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · AtropineStudies of AtropineAtropine pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.
Hyperbaric bupivacaine 10 mg + preservative-free morphine 100 µg + atropine sulphate 100 µg in 4 mL, single intrathecal injection before induction
Lidocaine, fentanyl, propofol, rocuronium induction; sevoflurane maintenance; neostigmine-atropine reversal
Paracetamol 1 g and ketorolac 30 mg IV at skin closure; ondansetron 4 mg IV at end of anaesthesia
Incidence of postoperative nausea and vomiting (PONV)
Proportion of participants with a score of 1 or more on a 5-point PONV analogue visual scale (0 = none; 1 = nausea \<10 min or one vomit, no treatment; 2 = nausea \>10 min or two vomits, no treatment; 3 = nausea \>10 min or more than two vomits requiring treatment; 4 = refractory to treatment), assessed at 1 h in recovery and at 2, 6, 12 and 24 h on the ward. Higher scores indicate worse outcome.
Time frame: Within 24 hours after surgery
Postoperative pain intensity
11-point Numeric Rating Scale, 0 = no pain to 10 = worst imaginable pain; higher = worse.
Time frame: 2, 6, 12 and 24 hours after surgery
Number of participants requiring rescue morphine
morphine 2 mg IV given for NRS greater than 6.
Time frame: Within 24 hours
Number of participants requiring rescue ondansetron
ondansetron 4 mg IV given for PONV score of 3 or more.
Time frame: Within 24 hours
Total post-induction fentanyl dose
Total post-induction fentanyl dose
Time frame: Intraoperative period, from induction to end of anaesthesia
Mean arterial pressure
mmHg, non-invasive.
Time frame: Pre-induction, after spinal injection, at and after insufflation, after desufflation, after extubation (intraoperative period)
Heart rate
beats per minute
Time frame: Pre-induction, after spinal injection, at and after insufflation, after desufflation, after extubation (intraoperative period)
Number of participants requiring vasopressor support
Time frame: Intraoperative period
Number of participants with heart rate below 50 beats/min
as a safety measure for the intrathecal atropine.
Time frame: intraoperative
Plan to share: No — Individual participant data will not be shared. The informed consent obtained from participants and the ethics approval for this study provided for research data to be kept confidential, with access limited to regulatory authorities for verification purposes, and did not include provision for sharing individual-level data with third parties.
No publications or documents are linked to this record.
Ran from Feb 2026 to primary completion in Mar 2026, 1 month.
Of 68 non-industry phase 4 interventional studies under Postoperative Nausea and Vomiting, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's 1 month is below that.
Counting every sponsor, half of 68 studies reached it within 11 months; a quarter within 5 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Bupivacaine · Morphine · Atropine
Postoperative Nausea and Vomiting →
Universitas Indonesia